Wednesday, November 4, 2009
Dengue Test
INTRODUCTION
Dengue is a flavivirus transmitted in the tropics and involves both humans abd Aedes mosquitos. The 4 serotypes of dengue (DEN-1, -2, -3 and -4) are similar, but are antigenically different. This implies that infection with one of the serotypes only provides cross-protective immunity for a few of months.
IgM antibodies are detectable within 5 days and persist for 2-3 months while IgG antibodies appear a few days later and provide a lifelong immunity.
PRINCIPLE
The dengue test employs colloidal gold particles coated with different recombinant dengue envelope proteins. When a specimen (serum) containing anti-dengue IgG and/or IgM antibodies is added to the test, the antibodies react with the dengue envelope proteins resulting in immune complexes which migrate along the membrane and are captured by monoclonal anti-human IgG in the first line and/or IgM in the second. The excess immune complexes then migrate further before binding to anti-dengue IgG which are coated on the control line.
If there are no dengue antibodies present in the specimen, only the control line will appear.
Note: The control line must appear in every test and the absence of the control line might indicates improper usage or the deterioration of the reagents.
Thank You
Stanley
0702201E
Thursday, October 29, 2009
RNA extraction from tissues
Procedures for RNA extraction from tissues:
1. pre-weigh an empty cryovial
2. take the tissue specimen out from the cryovial and place it on a 100mm petri dish
3. use a scapel and sterican (like fork and knife) to cut the tissue into desired size
4. transfer the tissue into the pre-weigh cryovial and weigh again (this will give the exact weigh of the tissue being process)
5. transfer the surplus tissue into the original cryovial and keep in the nitrogen tank
6. add 650µl of RLT buffer into the cryovial
7. pound the tissue using a pipette tip until the solution turn orange in colour.
8. transfer the solution into QIA shredder column and centrifuge at 14 000rpm for 4minutes
9. transfer the flow through into a new eppendorf tube and add in 550µl of 70% ethanol
10. centrifuge the eppendorf tube at 14 000rpm for 3 minutes
11. transfer the solution into Rneasy column and centrifuge at 14 000rpm for 15 seconds
12. discard the flow through
13. add 700µl RW1 buffer into the Rneasy column and centrifuge at 14 000rpm for 15 seconds
14. discard the flow through
15. add 500µl RPE buffer into the Rneasy column and centrifuge at 14 000rpm for 15 seconds
16. discard the flow through
17. centrifuge the Rneasy column at 14 000rpm for 1 minute
18. transfer the Rneasy column into a new sterilised round bottom tube
19. add 30µl Rnase-free water and centrifuge at 14 000rpm for 1 minute
20. transfer the flow into the column and centrifuge at 14 000rpm for 1 minute
21. the flow through is the RNA extracted
Thing to note
- after taking the cryovial of tissue out from the nitrogen tank, keep it in liquid nitrogen.
Yeo Sok Kian Jocelyn
0703359J
Monday, October 26, 2009
Immunochemistry- G6PD quantification
This time I am going to talk about the quantitative determination of G6PD on an analyzer, which is currently undergoing evaulation.
Principle
The principle of the assay is to utilize G6PD (that is present in the RBCs) that catalyzes the oxidation of glucose-6-phosphate (G6P) to 6-Phosphogluconolactone (6PG). This takes place in the presence of NADP, which will be reduced to NADPH. The NADPH produced will then react with a colour reagent to produce a fluorescence that will be measured colourimetrically at 550nm.
What is G6PD
G6PD is an important cytoplasmic enzyme that is found in cells and plays a crucial role in reducing the oxidative effect of the free radicals on the RBCs. It is involve in the first step of the hexose-monophosphate pathway (HMP) to produced NADPH, which is essential in maintaining the integrity of the RBCs membrane. Hence, with a deficiency of this enzyme, the RBCs are prone to lysis due to the oxidative stress. And this may lead to hemolytic anaemia.
Why do this test?
An awareness of G6PD deficiency had been raised many years back in Singapore. Hence, all newborns will be screened for this deficiency. And of course, the samples used for this test will be all cord blood samples.
How does the assay work?
First, all the samples will be transferred manually into eppendorf tubes and loaded onto the analyzer. Next, an elution buffer will then be added to the blood to lyse the RBCs. This is to bring out the enzyme, if it is present. The reagent solution is then added for the production of NADPH in the presence of G6PD. After which, the colour reagent will be added for colour production if NADPH is produced. Incubation will take place before the absorbance reading is taken.
The quantitative results will then be calculated after the readings are entered onto Excel. For deficient samples, they will be re-run again to confirm whether if the enzyme is really absent.
That should be all! (: Feel free to ask me any questions, I will try my best to answer them.
Posted by: Tan Siew Ming
0702862D
Wednesday, October 7, 2009
research: BCA assay
Sunday, October 4, 2009
CK-MB test
The determination of CKMB is an important element in the diagnosis of myocardiac ischemia. CKMB is detectable in the blood about 3-8 hours after the onset of cardiac symptoms and can be detectable over a period of time which is dependant on the course of the condition.
Test principle
Sandwich principle
- 1st incubation: 15uL of sample, a biotinlylated monoclonal anti CK-MB antibody, and a monoclonal CK-MB specific antibody labeled with a ruthenium complex react to form a sandwich complex.
- 2nd incubation: After addition of streptavidin-coated microparticles, the complex becomes bound to the solid phase via interaction of biotin and streptavidin
- The reaction mixture is aspirated into the measuring cell where the microparticles are magnetically captured onto the surface of the electrode. Unbound substances are then washed away.
- Results are determined bia a calibration curve which is instrument-specifically generated by 2 point calibration and a master curve provided via the reagent barcode.
Note: The entire test is done using the analyzer (Cobas e) and the test principle can be found inside the CK-MB kit.
Stanley
Wednesday, September 30, 2009
G6PD qualitative screening test
G6PD is a key enzyme in the hexose monophosphate pathway (HMP) and is required for the formation of NADPH. NADPH is essential for maintaining the integrity of the erythrocyte membrane.
Specimen collection and preparation
- Process specimen collected in EDTA tube
- Before analysis, check that the specimen is not clotted
Clinically significance
G6PD deficiency may be cause of hemolytic disease of newborns in Asian Mediterranean. Drug-induced hemolytic anaemia is most commonly associated in erythrocyte deficiencies of G6PD.
This deficiency is due to presence of a labile G6PD enzyme that is present in young cells but rapidly disappears with cell aging. A range of variant defective enzymes have been found in different racial group.
Performing G6PD screening test by R&D diagnostic G6PD deficiency screening test kit
- Label a filter paper (in test kit) with the running number
- Label 4 spaces in filter paper for Blank, Normal, Intermediate and Deficient control
- Pipette 100µ of substrate into all the tubes. Substrate must be at room temperature for test
- Mix the Normal control (a previous day’s specimen with G6PD present). Pipette 5µl into its labeled test tube containing the substrate, mix and immediately start the timer
- Using a sufficient time interval between sample, mix the Intermediate control and likewise pipette 5µl into its labeled test tube of substrate and mix.
- With the same time interval between samples, pipette the Deficient control and test samples accordingly
- When the timer reaches 10minutes, mix and pipette 10µl of the Normal control mixture onto its labeled portion on the filter paper
- Following the same time interval between samples, likewise mix and pipette the Deficient, Intermediate controls and the rest of the samples into their labeled position on the filter paper
- Pipette 10µl of the working substrate onto the position labeled “Blank”. Allow filter paper to dry completely and place it in the ultraviolet viewing cabinet
- Close the “Frontal Access Door” and switch on the “Long wave switch”
- View fluorescent through the viewing port which has ultraviolet absorbing filter to protect the eyes and increased fluorescent contrast
- Specimen from patient with normal G6PD activity will show strong fluorescence. Failure to fluorescence after 10minutes incubation suggests a total lack or marked deficiency of G6PD
- Strong fluorescence as compared to the intensity of the positive control, report as present. Report doubtful for weak or no fluorescence as compared with the intensity of the Intermediate deficient control
- Check doubtful specimen for blood clots
o If clot, repeat test with new specimen
o If no clot, repeat test
o All doubtful specimen are required to do G6PD quantitative determination
Yeo Sok Kian Jocelyn
0703359J
Monday, September 28, 2009
Freezing of cells
Protocol (For freezing 1ml)
1. Trypsinize cells
2. Count cells
3. Resuspend cells with medium (Cell density should be ~50 000 - 1 000 000 cells/ml)
4. Add 900ul of cell suspension and 100ul of (Dimethyl Sulfoxide)DMSO into a cryovial.
5. Freeze at -80 degree celsius or -196 degree celsius.
Note: DMSO acts like a cryoprotectant which prevents damage arising from freezing.
Alvin